| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $189.6M | +9.8% |
| SG&A Expense | $64.4M | +18.0% |
| Operating Income | -$299.5M | -31.8% |
| Pre-tax Income | -$292.9M | -23.3% |
| Income Tax | -$601K | -28.1% |
| Net Income | -$292.2M | -23.4% |
| EPS (Basic) | -$4.47 | +0.2% |
| EPS (Diluted) | -$4.47 | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.0M | -34.9% |
| Current Assets | $496.7M | +9.9% |
| Total Assets | $551.7M | +2.3% |
| Current Liabilities | $69.4M | +22.5% |
| Total Liabilities | $114.3M | +8.6% |
| Stockholders' Equity | $437.3M | +0.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$207.8M | -26.9% |
| Capital Expenditures | $583K | -77.1% |
| Investing Cash Flow | -$44.5M | +61.1% |
| Financing Cash Flow | $237.3M | -9.1% |
| Free Cash Flow | -$208.4M | -25.3% |